CLINICAL_TRIALS
trial_result
· 2016-11-18
Clinical Trial Update: A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma [Phase 2]
Summary
This is a completed Phase 2 study evaluating the effect of fingolimod (FTY720) on pulmonary function in adults with moderate asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Asthma | Phase 2 | Status: COMPLETED